Purdue David Ryan 4/A
4/A · AbbVie Inc. · Filed Mar 11, 2026
Research Summary
AI-generated summary of this filing
AbbVie SVP David Purdue Withholds 2,108 Shares for Taxes
What Happened
- David Purdue, SVP and Controller at AbbVie (ABBV), had 2,108 shares withheld to cover a tax liability (transaction code F) on February 27, 2026. The shares were valued at $232.08 each, for a total of about $489,225. This filing is an amendment correcting the number of shares withheld for taxes reported on the original Form 4.
Key Details
- Transaction date: 2026-02-27; withholding price: $232.08 per share; total value: ~$489,225.
- Transaction type: F — shares withheld to satisfy tax withholding/tax liability (not an open-market sale).
- Shares owned after the transaction: not disclosed in this amended Form 4.
- Footnote: The shares came from the AbbVie Savings Program balance as of Feb 20, 2026, which includes shares from a dividend reinvestment feature (F1).
- Filing timeline: original Form 4 was filed March 3, 2026; this amendment was filed March 11, 2026 to correct the withholding amount.
Context
- This was a routine tax-withholding/share-retention event (common when awards vest or options are exercised) rather than an open-market sale or purchase, so it should not be interpreted as a directional buy/sell signal. The amendment only corrects the reported number of shares withheld; all other previously reported information remains unchanged.
Insider Transaction Report
Form 4/AAmended
AbbVie Inc.ABBV
Purdue David Ryan
SVP, Controller
Transactions
- Tax Payment
Common Stock, $0.01 par value
2026-02-27$232.08/sh−2,108$489,225→ 8,468 total
Holdings
- 543(indirect: By Trust)
Common Stock, $0.01 par value
[F1]
Footnotes (1)
- [F1]Balance in AbbVie Savings program as of February 20, 2026. Balance includes shares acquired pursuant to a dividend reinvestment feature.
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for David R. Purdue|2026-03-11